HSI e-Alert - Preserve Access to Bioidentical HRT

[Guest guest]

" HSI - Jenny Thompson " <hsiresearch

HSI e-Alert - Preserve Access to Bioidentical HRT

Sun, 26 Feb 2006 12:59:00 -0500

 

 

 

Preserve Access to Bioidentical HRT

 

 

****************************************************

 

 

Dear Reader,

 

I just received this important message that I wanted to share with you

right away:

 

" Every day millions of women confront uncomfortable and sometimes

painful health problems related to menopause and hormone imbalances;

individualized treatment, including the use of Bioidentical Hormone

Replacement Therapy (BHRT) is proving to be a beneficial treatment

approach for many of those women.

 

" The Wyeth Corporation has petitioned the FDA against the production

of bioidentical hormones. If granted, the petition would undermine the

health care provider-patient relationship and limit women in their

access to BHRT.

 

" Visit http://www.democracyinaction.org here to send an email to FDA

Commissioner Andrew C. von Eschenbach urging him to reject Wyeth's

petition and preserve women's access to a broad range of health care

options. "

 

The link above provides a sample text you can use to easily send an

e-mail to the FDA.

 

You can find out much more about this vital health issue in the

e-Alert " Where's the Shame? " (2/7/06), which is available on our web

site at hsibaltimore.com.

 

Please help get the word out by passing this e-mail along to a friend.

 

To Your Good Health,

 

Jenny Thompson

 

*********************